ERCC1 and non-small cell lung carcinoma: The latest meta‐analysis in 2012 using 10 cohort studies with a total of 1252 NSCLC patients assessed that neither ERCC1 rs3212986 nor rs11615 variant had any influence on survival outcomes of platinum‐based treatment among advanced NSCLC patients 32.